Concepedia

Akemi Kuromiya

AK

5

Publications

243

Citations

5

H-Index

1998

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

University of Toronto

Toronto General Hospital

Akemi Kuromiya is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1998–2009

5

Publications

5

Novel, Highly Potent Aldose Reductase Inhibitors:  (<i>R</i>)-(−)-2-(4-Bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-<i>a</i>]pyrazine- 4-spiro-3‘-pyrrolidine-1,2‘,3,5‘-tetrone (AS-3201) and Its Congeners

Toshiyuki Negoro, Makoto Murata, S. UEDA et al. · Journal of Medicinal Chemistry · 1998 · 123 citations · Full text

, , +17

Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats

Takafumi Matsumoto, Yoshiyuki Ono, Masuo Kurono et al. · Journal of Pharmacological Sciences · 2008 · 50 citations · Full text

Long-Term Treatment With Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Suppresses Diabetic Neuropathy and Cataract Formation in Rats

Takafumi Matsumoto, Yoshiyuki Ono, Akemi Kuromiya et al. · Journal of Pharmacological Sciences · 2008 · 42 citations · Full text

Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury

Yasunao Inoue, Tomoki Omodani, Ryotaro Shiratake et al. · Bioorganic & Medicinal Chemistry · 2009 · 17 citations · Full text

, , +5

Improvement of Motor Nerve Conduction Velocity in Diabetic Rats Requires Normalization of the Polyol Pathway Metabolites Flux

Takafumi Matsumoto, Yoshiyuki Ono, Masuo Kurono et al. · Journal of Pharmacological Sciences · 2009 · 11 citations · Full text

Rows per page

1–5 of 5